Literature DB >> 34216541

The International Collaboration for Research methods Development in Oncology (CReDO) workshops: shaping the future of global oncology research.

Priya Ranganathan1, Girish Chinnaswamy2, Manju Sengar3, Durga Gadgil4, Shivakumar Thiagarajan5, Balram Bhargava6, Christopher M Booth7, Marc Buyse8, Sanjiv Chopra9, Chris Frampton10, Satish Gopal11, Nick Grant12, Mark Krailo13, Ruth Langley14, Prashant Mathur15, Xavier Paoletti16, Mahesh Parmar14, Arnie Purushotham17, Douglas Pyle18, Preetha Rajaraman19, Martin R Stockler20, Richard Sullivan21, Soumya Swaminathan22, Ian Tannock23, Edward Trimble24, Rajendra A Badwe25, C S Pramesh25.   

Abstract

Low-income and middle-income countries (LMICs) have a disproportionately high burden of cancer and cancer mortality. The unique barriers to optimum cancer care in these regions necessitate context-specific research. The conduct of research in LMICs has several challenges, not least of which is a paucity of formal training in research methods. Building capacity by training early career researchers is essential to improve research output and cancer outcomes in LMICs. The International Collaboration for Research methods Development in Oncology (CReDO) workshop is an initiative by the Tata Memorial Centre and the National Cancer Grid of India to address gaps in research training and increase capacity in oncology research. Since 2015, there have been five CReDO workshops, which have trained more than 250 oncologists from India and other countries in clinical research methods and protocol development. Participants from all oncology and allied fields were represented at these workshops. Protocols developed included clinical trials, comparative effectiveness studies, health services research, and observational studies, and many of these protocols were particularly relevant to cancer management in LMICs. A follow-up of these participants in 2020 elicited an 88% response rate and showed that 42% of participants had made progress with their CReDO protocols, and 73% had initiated other research protocols and published papers. In this Policy Review, we describe the challenges to research in LMICs, as well as the evolution, structure, and impact of CReDO and other similar workshops on global oncology research.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 34216541      PMCID: PMC8328959          DOI: 10.1016/S1470-2045(21)00077-2

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   54.433


  47 in total

1.  Unintended consequences of expensive cancer therapeutics—the pursuit of marginal indications and a me-too mentality that stifles innovation and creativity: the John Conley Lecture.

Authors:  Tito Fojo; Sham Mailankody; Andrew Lo
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2014-12       Impact factor: 6.223

2.  Prospective head and neck cancer research: a four-decade bibliometric perspective.

Authors:  Gordon H Sun; Jeffrey J Houlton; Nicholas M Moloci; Mark P MacEachern; Carol R Bradford; Mark E Prince; Reshma Jagsi
Journal:  Oncologist       Date:  2013-05-01

3.  Single-injection depot progesterone before surgery and survival in women with operable breast cancer: a randomized controlled trial.

Authors:  Rajendra Badwe; Rohini Hawaldar; Vani Parmar; Mandar Nadkarni; Tanuja Shet; Sangeeta Desai; Sudeep Gupta; Rakesh Jalali; Vaibhav Vanmali; Rajesh Dikshit; Indraneel Mittra
Journal:  J Clin Oncol       Date:  2011-06-13       Impact factor: 44.544

4.  Outcomes of a Telephone-Based Questionnaire for Follow-up of Patients Who Have Completed Curative-Intent Treatment for Oral Cancers.

Authors:  Akshat Malik; Sudhir Nair; Kavita Sonawane; Komal Lamba; Sarbani Ghosh-Laskar; Kumar Prabhash; Prathamesh Pai; Devendra Chaukar; Deepa Nair; Pankaj Chaturvedi
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2020-12-01       Impact factor: 6.223

Review 5.  Research on cancer prevention, detection and management in low- and medium-income countries.

Authors:  R Sankaranarayanan; P Boffetta
Journal:  Ann Oncol       Date:  2010-03-15       Impact factor: 32.976

Review 6.  Establishing translational and clinical cancer research collaborations between high- and low-income countries.

Authors:  T Peter Kingham; Olusegun I Alatise
Journal:  Ann Surg Oncol       Date:  2015-01-09       Impact factor: 5.344

7.  Cancer research in India: national priorities, global results.

Authors:  Richard Sullivan; Rajendra A Badwe; Goura K Rath; C S Pramesh; V Shanta; Raghunadharao Digumarti; Anil D'Cruz; Suresh C Sharma; Lokesh Viswanath; Arun Shet; Manavalan Vijayakumar; Grant Lewison; Mammen Chandy; Priyadarshini Kulkarni; M R Bardia; Shaleen Kumar; Rajiv Sarin; Paul Sebastian; Preet K Dhillon; Preetha Rajaraman; Edward L Trimble; Ajay Aggarwal; D K Vijaykumar; Arnie D Purushotham
Journal:  Lancet Oncol       Date:  2014-04-11       Impact factor: 41.316

8.  Evidence for non-communicable diseases: analysis of Cochrane reviews and randomised trials by World Bank classification.

Authors:  C Heneghan; C Blacklock; R Perera; R Davis; A Banerjee; P Gill; S Liew; L Chamas; J Hernandez; K Mahtani; G Hayward; S Harrison; D Lasserson; S Mickan; C Sellers; D Carnes; K Homer; L Steed; J Ross; N Denny; C Goyder; M Thompson; A Ward
Journal:  BMJ Open       Date:  2013-07-06       Impact factor: 2.692

Review 9.  Challenges in launching multinational oncology clinical trials in India.

Authors:  Kamal S Saini; Gaurav Agarwal; Ramesh Jagannathan; Otto Metzger-Filho; Monika L Saini; Khurshid Mistry; Raghib Ali; Sudeep Gupta
Journal:  South Asian J Cancer       Date:  2013-01

10.  Cancer Statistics, 2020: Report From National Cancer Registry Programme, India.

Authors:  Prashant Mathur; Krishnan Sathishkumar; Meesha Chaturvedi; Priyanka Das; Kondalli Lakshminarayana Sudarshan; Stephen Santhappan; Vinodh Nallasamy; Anish John; Sandeep Narasimhan; Francis Selvaraj Roselind
Journal:  JCO Glob Oncol       Date:  2020-07
View more
  4 in total

1.  Gordon McVie: his legacy as a blueprint for cancer advocates as we strive towards the 2030 global health and sustainable development goals.

Authors:  Gabriella Pravettoni; Marianna Masiero; Christine Mugo-Sitati; Julie Torode
Journal:  Ecancermedicalscience       Date:  2022-01-13

2.  Participation of Lower and Upper Middle-Income Countries in Clinical Trials Led by High-Income Countries.

Authors:  Fidel Rubagumya; Wilma M Hopman; Bishal Gyawali; Deborah Mukherji; Nazik Hammad; C S Pramesh; Mykola Zubaryev; Alexandru Eniu; Audrey T Tsunoda; Tezer Kutluk; Ajay Aggarwal; Richard Sullivan; Christopher M Booth
Journal:  JAMA Netw Open       Date:  2022-08-01

3.  Perspectives of Zambian Clinical Oncology Trainees in the MD Anderson and Zambia Virtual Clinical Research Training Program (MOZART).

Authors:  Kevin Diao; Darya A Kizub; Noveen Ausat; Catherine K Mwaba; Chidinma P Anakwenze Akinfenwa; Carrie A Cameron; Elizabeth Y Chiao; Dorothy C Lombe; Susan C Msadabwe; Lilie L Lin
Journal:  Oncologist       Date:  2022-10-01       Impact factor: 5.837

4.  NUAK2 and RCan2 participate in the p53 mutant pro-tumorigenic network.

Authors:  Eleonora Mammarella; Carlotta Zampieri; Emanuele Panatta; Gerry Melino; Ivano Amelio
Journal:  Biol Direct       Date:  2021-08-04       Impact factor: 4.540

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.